These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3543948)

  • 41. Distribution and metabolism of adriamycin in mice. Comparison with daunomycin.
    Di Fronzo G; Gambetta RA; Lenaz L
    Rev Eur Etud Clin Biol; 1971; 16(6):572-6. PubMed ID: 5125106
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
    Li ZR; Feng JB; Liang F; Zeng SX; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of anthracyclines with plasma membranes from tumour cells: implications on drug resistance.
    González-Ros JM; Ferrer-Montiel AV; Soto F; Escriba PV; Ferragut JA
    Biochem Soc Trans; 1989 Dec; 17(6):964-5. PubMed ID: 2697620
    [No Abstract]   [Full Text] [Related]  

  • 45. Facile exchange of the cyano group in highly potent anticancer cyanomorpholinyl anthracyclines.
    Peters JH; Gordon GR; Nolen HW; Tracy M; Thomas DW
    Biochem Pharmacol; 1988 Jan; 37(2):357-61. PubMed ID: 3422560
    [No Abstract]   [Full Text] [Related]  

  • 46. The structure of SN-07 chromophore.
    Kimura K; Nakayama S; Miyata N; Takeshita Y; Kawanishi G
    J Antibiot (Tokyo); 1988 Mar; 41(3):411-4. PubMed ID: 3366698
    [No Abstract]   [Full Text] [Related]  

  • 47. Interactions of antineoplastic antibiotics and DNA.
    Gause GF; Dudnik YV
    Antibiot Chemother (1971); 1980; 28():102-8. PubMed ID: 6158286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo effects of several anthracyclines on DNA integrity.
    Londos-Gagliardi D; Aubel-Sadron G
    FEBS Lett; 1982 Jun; 142(1):17-22. PubMed ID: 6955190
    [No Abstract]   [Full Text] [Related]  

  • 49. Microbial conversion of anthracycline antibiotics. III. Glycosidation of natural and chemically synthesized anthracycline aglycones.
    Hoshino T; Setoguchi Y; Fujiwara A
    J Antibiot (Tokyo); 1984 Nov; 37(11):1469-72. PubMed ID: 6595254
    [No Abstract]   [Full Text] [Related]  

  • 50. Structures, properties and disposition of drugs.
    Lien EJ
    Prog Drug Res; 1985; 29():67-95. PubMed ID: 2868488
    [No Abstract]   [Full Text] [Related]  

  • 51. Aspects of cytotoxic drug penetration, with particular reference to anthracyclines.
    Kerr DJ; Kaye SB
    Cancer Chemother Pharmacol; 1987; 19(1):1-5. PubMed ID: 3545523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of nucleosomes with anthracycline antibiotics: relevance to anticancer activity.
    Palumbo M; Cera C; Marciani-Magno S; Palù G
    Biochem Pharmacol; 1988 May; 37(9):1871-2. PubMed ID: 3163927
    [No Abstract]   [Full Text] [Related]  

  • 53. New natural products of interest under development at the National Cancer Institute.
    Douros J; Suffness M
    Cancer Chemother Pharmacol; 1978; 1(2):91-100. PubMed ID: 86390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anthracycline resistance.
    Bhushan A; Kermode JC; Posada J; Tritton TR
    Cancer Treat Res; 1989; 48():55-72. PubMed ID: 2577141
    [No Abstract]   [Full Text] [Related]  

  • 55. Infusional anthracyclines: is slower better? If so, why?
    Workman P
    Ann Oncol; 1992 Sep; 3(8):591-4. PubMed ID: 1450039
    [No Abstract]   [Full Text] [Related]  

  • 56. Use of pharmacokinetic-pharmacodynamic relationships in the development of new anthracyclines.
    Robert J
    Cancer Chemother Pharmacol; 1993; 32(2):99-102. PubMed ID: 8485814
    [No Abstract]   [Full Text] [Related]  

  • 57. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 58. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.
    Kessel D
    Cancer Surv; 1986; 5(1):109-27. PubMed ID: 3297311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mode of action of calcium antagonists which alter anthracycline resistance.
    Kessel D; Wilberding C
    Biochem Pharmacol; 1984 Apr; 33(7):1157-60. PubMed ID: 6585204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.